Oklahoma Board of Pharmacy Disciplines Prescriptions Compounding Pharmacy for compounding commercially available drugs that were essentially a copy of an FDA-approved drug

Prescriptions Compounding Pharmacy, #2-5915 – Case No. 1370: Agreed to guilt on nine counts including compounding a drug product that is commercially available in the marketplace or that is essentially a copy of an available Food and Drug Administration (FDA)-approved drug product; failing to ensure that preparations are of acceptable strength, quality, and purity; failing to verify all critical processes; and failing to be familiar with all details of USP compounding standards. Two years’ probation until December 3, 2017, and $4,000 fine.
Trisha Ann Henson, DPh #15523 – Case No. 1371: Agreed to guilt on nine counts including compounding a drug product that is commercially available in the marketplace or that is essentially a copy of an available FDA-approved drug product; failing to ensure that preparations are of acceptable strength, quality, and purity; failing to verify all  critical processes; and failing to be familiar with all details of USP compounding standards. Two years’ probation until December 3, 2017, and $2,000 fine. Shall attend a one-day (eight-hour) law seminar in addition to the required 15 hours of CE during the calendar years of 2016 and 2017. All 15 hours of required CE that respondent must have to renew her license shall be live during her two years of probation. Respondent shall attend a Board-approved compounding course by March 1, 2016.


source:  Oklahoma Board of Pharmacy April 2016 Newsletter